SHLT Key Statistics, Chart & Performance
The current stock price of SHLT is 2.05 USD. In the past month the price decreased by -17.37%. In the past year, price decreased by -67.44%.
SHLT Latest News, Press Relases and Analysis
SHLT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.49 | 99.91B | ||
| CI | THE CIGNA GROUP | 9.25 | 70.18B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 118.23 | 21.75B | ||
| LH | LABCORP HOLDINGS INC | 16.46 | 21.59B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.45 | 20.03B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.25B | ||
| HIMS | HIMS & HERS HEALTH INC | 70.58 | 8.68B | ||
| DVA | DAVITA INC | 12.67 | 8.26B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 34.41 | 6.33B | ||
| CHE | CHEMED CORP | 19.21 | 5.99B | ||
| RDNT | RADNET INC | 197.26 | 5.78B | ||
| OPCH | OPTION CARE HEALTH INC | 21.67 | 5.13B |
Related stock screener links
About SHLT
Company Profile
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Company Info
SHL TELEMEDICINE LTD-ADR
Yigal Alon 90
TEL AVIV-YAFO IL
Employees: 583
Phone: 97235612212
SHL TELEMEDICINE LTD-ADR / SHLT FAQ
Can you describe the business of SHL TELEMEDICINE LTD-ADR?
SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.
Can you provide the latest stock price for SHL TELEMEDICINE LTD-ADR?
The current stock price of SHLT is 2.05 USD. The price decreased by -1.44% in the last trading session.
Does SHL TELEMEDICINE LTD-ADR pay dividends?
SHLT does not pay a dividend.
How is the ChartMill rating for SHL TELEMEDICINE LTD-ADR?
SHLT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of SHLT stock?
SHL TELEMEDICINE LTD-ADR (SHLT) operates in the Health Care sector and the Health Care Providers & Services industry.
Can you provide the market cap for SHL TELEMEDICINE LTD-ADR?
SHL TELEMEDICINE LTD-ADR (SHLT) has a market capitalization of 33.60M USD. This makes SHLT a Nano Cap stock.
Can you provide the upcoming earnings date for SHL TELEMEDICINE LTD-ADR?
SHL TELEMEDICINE LTD-ADR (SHLT) will report earnings on 2025-04-24.
SHLT Technical Analysis
SHLT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SHLT. SHLT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
SHLT Financial Highlights
Over the last trailing twelve months SHLT reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -282.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -8.6% | ||
| ROE | -13.13% | ||
| Debt/Equity | 0.2 |